GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Agimexpharm Pharmaceutical JSC (HSTC:AGP) » Definitions » Debt-to-Revenue

Agimexpharm Pharmaceutical JSC (HSTC:AGP) Debt-to-Revenue : 0.00 (As of . 20)


View and export this data going back to 2015. Start your Free Trial

What is Agimexpharm Pharmaceutical JSC Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Agimexpharm Pharmaceutical JSC's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₫0.00 Mil. Agimexpharm Pharmaceutical JSC's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₫0.00 Mil. Agimexpharm Pharmaceutical JSC's annualized Revenue for the quarter that ended in . 20 was ₫0.00 Mil.


Agimexpharm Pharmaceutical JSC Debt-to-Revenue Historical Data

The historical data trend for Agimexpharm Pharmaceutical JSC's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Agimexpharm Pharmaceutical JSC Debt-to-Revenue Chart

Agimexpharm Pharmaceutical JSC Annual Data
Trend
Debt-to-Revenue

Agimexpharm Pharmaceutical JSC Semi-Annual Data
Debt-to-Revenue

Competitive Comparison of Agimexpharm Pharmaceutical JSC's Debt-to-Revenue

For the Drug Manufacturers - General subindustry, Agimexpharm Pharmaceutical JSC's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Agimexpharm Pharmaceutical JSC's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Agimexpharm Pharmaceutical JSC's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Agimexpharm Pharmaceutical JSC's Debt-to-Revenue falls into.



Agimexpharm Pharmaceutical JSC Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Agimexpharm Pharmaceutical JSC's Debt-to-Revenue for the fiscal year that ended in . 20 is calculated as

Agimexpharm Pharmaceutical JSC's annualized Debt-to-Revenue for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is one times the quarterly (. 20) Revenue data.


Agimexpharm Pharmaceutical JSC Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Agimexpharm Pharmaceutical JSC's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Agimexpharm Pharmaceutical JSC (HSTC:AGP) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
27 Nguyen Thai Hoc, My Binh Ward, An Giang Province, Long Xuyen, VNM
Agimexpharm Pharmaceutical JSC is engaged in manufacturing of pharmaceuticals, medicinal chemicals and botanical products.

Agimexpharm Pharmaceutical JSC (HSTC:AGP) Headlines

No Headlines